BRIACELL THERAPEUTICS CORP.

Profile

Company Names

BRIACELL THERAPEUTICS CORP.
ANSELL CAPITAL CORP.

Addresses

SUITE 300-235 15TH STREET, WEST VANCOUVER, A1 V7T2X1

SUITE 300, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, A1 V7T 2X1

3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, A1 V7T 2X1

Phone Numbers

(604) 921-1810

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$34,301,375.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-06-03 
$27,195,924.00 
$27,195,924.00 
$0.00 
Equity 
3
2018-03-27 
$800,000.00 
$800,000.00 
$0.00 
Debt 
2
2014-11-27 
$6,006,150.00 
$6,006,150.00 
$0.00 
Equity 
1
2014-05-23 
$299,301.00 
$881,274.00 
$581,973.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAEID 
 
BABAEI 
DIRECTOR
SAEID 
 
BABEI 
DIRECTOR
JAMIESON 
 
BONDARENKO 
EXECUTIVE OFFICER, DIRECTOR
VAUGHN 
 
EMBRO-PANTALONY 
DIRECTOR
BEV 
 
FUNSTON 
EXECUTIVE OFFICER, DIRECTOR
CHRIS 
 
HEALEY 
DIRECTOR
ISAAC 
 
MARESKY 
DIRECTOR
MARTIN 
 
SCHMIEG 
DIRECTOR
RAHOUL 
 
SHARAN 
DIRECTOR, EXECUTIVE OFFICER
RAHOUL 
A. 
SHARAN 
EXECUTIVE OFFICER, DIRECTOR
JEVIN 
 
WERBES 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
 
WILLIAMS 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
V. 
WILLIAMS 
EXECUTIVE OFFICER, DIRECTOR
CHARLES 
 
WISEMAN 
EXECUTIVE OFFICER, DIRECTOR
MATTHEW 
G. 
WRIGHT 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-06-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-03-27 
D
BIOTECHNOLOGY 
 
NOT APPLICABLE 
Equity 
2014-11-27 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC.
NONE
NONE
NEWBRIDGE SECURITIES CORPORATION (LIFETECH CAPITAL DIVISION)